The webinars below include a small fee and provide CME (free for CSAM members). These two webinars were created with the support of a grant funded by the California Department of Healthcare Services (DHCS).

The number of X-waivered providers in California is increasing.  Many primary care providers are now doing office-based care of patients with opioid use disorder.  This webinar will showcase common, challenging situations that arise for patients being maintained on buprenorphine.  Expert discussants will talk through cases to teach the learner practical management tips. 
Presenters: Soraya Azari, MD, Kenneth Saffier, MD, FASAM and Scott Steiger, MD, FACP, FASAM

This webinar will review the complexities of carrying out buprenorphine inductions among patients with co-morbid pain, and a novel approach for managing these transitions.
Presenters: Soraya Azari, MD and Tauheed Zaman, MD

Fundamentals to Advanced Buprenorphine (Recorded 9/4/2019) (2 hours)

This workshop, part of the Addiction Medicine Review Course 2019 focuses on the modern prescribing of buprenorphine for opioid use disorder. Core topics of pharmacology, side effect management, and regulations of buprenorphine treatment are covered. 
Presenters: David Kan, MD, DFASAM, Farah Zaidi, MD, Matthew A. Torrington, MD, Joseph Mega, MD, MPH

Pre-Recorded MAT Webinars (one hour)

The webinars below include a small fee and provide CME credit (free for CSAM members). PA’s, nurses, pharmacists, psychologists and therapists can earn CEU credit. The webinars are available for free without CME credit on the California Health Care Foundation website

Managing Acute and Perioperative Pain in Patients on Medication-Assisted Treatments (Recorder March 24, 2017)
This webinar will discuss the best evidence for management of acute and perioperative pain for patients on buprenorphine, methadone and  naltrexone formulations for substance use disorders. We will cover strategies for patient preparation and communication with the perioperative team. 
Presenter: Andrea Rubinstein, MD 


Tapering Long-Term Opioids (Recorded April 28, 2017)
With recent changes in guidelines designed to improve the safety of long-term opioid therapy, many prescribers have initiated opioid tapering programs though little is known about the risks and benefits of opioid tapering.  Possible risks of opioid tapering include worsened pain or function as well as identification of previously undiagnosed opioid use disorder. This webinar provides a brief background and review the available evidence to guide patient-centered tapering of long-term opioid therapy. We will provide strategies for clinicians to discuss tapering with their patients and get patient buy-in as well as resources to help implement opioid tapers.
Presenter: Joseph Frank, MD, University of Colorado School of Medicine, VA Eastern Colorado Health System


Naloxone Prescribing in Primary Care: Why, Who, and How / Diana Coffa, MD   (Recorded May 19, 2017)
Opioid overdose deaths rates are climbing and primary care physicians are on the front lines. Naloxone has revolutionized overdose prevention among people who use heroin but is underutilized in people who use prescription opioids. In this webinar, we will examine the history of naloxone, evidence for prescribing it in primary care, tips for getting patient buy-in, and strategies for implementing prescription programs in resource-limited settings.
Presenter: Diana Coffa, MD, Associate Professor, Residency Program Director, Family and Community Medicine UCSF 


Complex Chronic Pain, Opioid Prescribing and Opioid Use Disorder: Pitfalls, Pearls and New Directions / William C. Becker, MD (Recorded June 23, 2017)
Chronic pain is widely prevalent and often treated with opioids, which can be complicated by low efficacy, safety issues, misuse and opioid use disorder. In this case-based webinar, we will discuss practical approaches to diagnosis and treatment with a special focus on communication tips to support patients, providers, and staff as they navigate challenging clinical scenarios.
Presenter: William C. Becker, MD, Core Investigator: Pain Research, Informatics, Multimorbidities & Education (PRIME) Center of Innovation, VA Connecticut Healthcare System; Assistant Professor, Yale University School of Medicine


How to Build a Controlled Substance Review Committee in Your Primary Care Clinic: Why? Who? How?  (Recorded July 28, 2017)
Is your primary care clinic struggling to navigate cultural changes around chronic pain and opioid management? Why not look into creating an internal peer-review committee for complex pain cases? If done right, it can improve the experience of both patients and providers. This webinar will use a case-based format to review the basic structure and composition of such a committee, the operations, and the benefits to its use. 
Presenter: Soraya Azari, MD


Transitioning High-Dose Opioid Chronic Pain Patients to Buprenorphine (Recorded September 22, 2017)
Case-based webinar will address patients with chronic non-cancer pain who have been maintained on high dose opioids (> 90-250MED) for months years without improvement in functional outcome and break out characteristics of what is increasingly being called the "Lost Generation:" patients taking in excess of 240 MED. The speaker will present one clinician's approach to these patients including the clinical importance of withdrawal and harm reduction strategies such as naloxone kits, supporting patients through tapering, if tapers fail, transitioning to buprenorphine from higher dose opioids to improve safety in high-risk cohort.
Presenter: Paul Coelho, MD


Medication-Assisted Treatment for Alcohol Use Disorder: A Guide for Primary Care Providers (Recorded 10/27/2017)
Alcohol use disorder (AUD) is common in primary care where the bulk of these patients are seen -often for its complications- but medications to treat AUD remain underutilized in this setting. Primary care physicians can and should prescribe medications to help patients reduce their alcohol use. This practical webinar will cover the basics of when to provide medications for this disorder and what patient characteristics to keep in mind when choosing from the 4 FDA approved medications available.
Presenter: Steven Batki, MD